NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,996,175 | +116.7% | 2,466,205 | -0.0% | 2.21% | +79.9% |
Q2 2023 | $11,073,301 | -1.7% | 2,466,214 | +1.5% | 1.23% | +5.5% |
Q1 2023 | $11,269,233 | +219.3% | 2,428,714 | +2.5% | 1.17% | +130.6% |
Q4 2022 | $3,529,814 | -59.7% | 2,369,003 | +1.5% | 0.51% | -57.4% |
Q3 2022 | $8,753,000 | -24.2% | 2,334,003 | 0.0% | 1.19% | -34.0% |
Q2 2022 | $11,553,000 | -39.4% | 2,334,003 | +0.4% | 1.80% | -26.8% |
Q1 2022 | $19,080,000 | -18.0% | 2,324,003 | +0.6% | 2.46% | +5.7% |
Q4 2021 | $23,275,000 | -12.1% | 2,309,003 | +38.3% | 2.33% | -43.5% |
Q3 2021 | $26,472,000 | -19.6% | 1,670,136 | +20.6% | 4.12% | -18.6% |
Q2 2021 | $32,935,000 | – | 1,384,387 | – | 5.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 1,670,136 | $26,472,000 | 4.12% |
Orbimed Advisors | 4,012,281 | $63,595,000 | 0.70% |
SECTORAL ASSET MANAGEMENT INC | 444,572 | $7,046,000 | 0.59% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 453,012 | $7,180,000 | 0.11% |
Bellevue Group AG | 507,930 | $8,051,000 | 0.08% |
JOHNSON & JOHNSON | 55,435 | $879,000 | 0.08% |
Nantahala Capital Management | 141,641 | $2,245,000 | 0.07% |
LORD, ABBETT & CO. LLC | 359,421 | $5,697,000 | 0.01% |
PICTET ASSET MANAGEMENT SA | 569,875 | $9,033,000 | 0.01% |
Ghisallo Capital Management LLC | 15,000 | $238,000 | 0.01% |